RUNX1 and acute myeloid leukemia: Introduction of additional co-operating mutations in CSF3R or RUNX1 in reprogrammed patient cells harboring ELANE mutation identified the upregulation of BAALC and phosphorylation of MK2a as key pathological events of progression of CN to CN/AML.